TIDMGSK

RNS Number : 3631K

GlaxoSmithKline PLC

04 May 2022

GlaxoSmithKline plc

Results of 22(nd) Annual General Meeting

GlaxoSmithKline plc ('GSK') held a hybrid Annual General Meeting ('AGM') at 2.30pm on Wednesday 4 May 2022. Shareholders were able to join virtually via Lumi, Zoom and in person at the meeting held at the Sofitel Hotel in Terminal 5 Heathrow.

All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll taken at the meeting.

The table below shows the results of the poll on all 28 resolutions. The full text of the resolutions is contained in the Notice of AGM published on 28 March 2022, which is available on GSK's website at www.gsk.com .

 
 Resolution                      Total votes     %       Total votes     %       Total votes     Votes 
                                  for (1)(2)              against                 cast            withheld 
                                                          (2)                                     (3) 
      Receive and adopt 
       the 2021 Annual 
 1     Report                    3,524,582,633   99.01      35,137,552    0.99   3,559,720,185   11,843,164 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Approve the Annual 
 2     report on remuneration    3,240,737,115   91.05     318,510,405    8.95   3,559,247,520   12,317,062 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Approve the Remuneration 
 3     Policy                    2,197,755,545   61.76   1,360,515,540   38.24   3,558,271,085   13,294,793 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Election of Dr 
 4     Anne Beal                 3,546,443,179   99.55      16,055,842    0.45   3,562,499,021    9,042,781 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Election of Dr 
 5     Harry Dietz               3,545,845,271   99.54      16,469,238    0.46   3,562,314,509    9,224,475 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 6     Sir Jonathan Symonds      3,482,374,837   97.76      79,898,313    2.24   3,562,273,150    9,274,730 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 7     Dame Emma Walmsley        3,555,195,651   99.79       7,564,971    0.21   3,562,760,622    8,806,465 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 8     Charles Bancroft          3,503,934,446   98.36      58,393,472    1.64   3,562,327,918    9,214,474 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 9     Vindi Banga               3,483,288,426   97.79      78,881,291    2.21   3,562,169,717    9,373,841 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 10    Dr Hal Barron             3,546,018,185   99.54      16,347,031    0.46   3,562,365,216    9,173,855 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 11    Dr Vivienne Cox           3,531,865,048   99.14      30,474,324    0.86   3,562,339,372    9,204,548 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 12    Lynn Elsenhans            3,476,281,291   97.58      86,142,909    2.42   3,562,424,200    9,118,541 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 13    Dr Laurie Glimcher        3,556,622,114   99.84       5,547,225    0.16   3,562,169,339    9,375,696 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 14    Dr Jesse Goodman          3,555,655,121   99.82       6,515,409    0.18   3,562,170,530    9,367,820 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 15    Iain Mackay               3,551,784,186   99.71      10,432,989    0.29   3,562,217,175    9,333,434 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-election of 
 16    Urs Rohner                3,410,175,068   95.74     151,806,419    4.26   3,561,981,487    9,561,680 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Re-appointment 
 17    of the auditor            3,557,280,686   99.84       5,797,033    0.16   3,563,077,719    8,481,780 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Remuneration of 
 18    the auditor               3,555,233,064   99.86       5,000,395    0.14   3,560,233,459   11,338,880 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Authority for the 
       company to make 
       donations to political 
       organisations and 
       incur political 
 19    expenditure               3,493,409,287   98.64      48,161,797    1.36   3,541,571,084   30,003,446 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Authority to allot 
 20    shares                    3,430,993,149   96.35     130,127,471    3.65   3,561,120,620   10,593,875 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Disapplication 
       of pre-emption 
       rights - general 
 21    power (4)                 3,460,375,320   97.24      98,220,644    2.76   3,558,595,964   12,963,416 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Disapplication 
       of pre-emption 
       rights - in connection 
       with an acquisition 
       or specified capital 
 22    investment (4)            3,404,168,390   95.65     154,942,194    4.35   3,559,110,584   12,448,092 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Authority for the 
       company to purchase 
       its own shares 
 23    (4)                       3,517,497,794   98.79      43,085,674    1.21   3,560,583,468   10,990,502 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Exemption from 
       statement of senior 
       statutory auditor's 
 24    name                      3,523,554,816   99.59      14,359,955    0.41   3,537,914,771   33,655,391 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Authority for reduced 
       notice of a general 
       meeting other than 
 25    an AGM (4)                3,331,432,180   93.62     227,176,994    6.38   3,558,609,174   12,950,914 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Approve the Share 
 26    Save Plan 2022            3,508,449,940   98.62      49,235,709    1.38   3,557,685,649   13,896,262 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Approve the Share 
 27    Reward Plan 2022          3,516,666,377   98.86      40,690,090    1.14   3,557,356,467   14,160,284 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
      Approve the adoption 
       of new Articles 
       of Association 
 28    (4)                       3,549,030,121   99.80       6,964,097    0.20   3,555,994,218   15,501,889 
     -------------------------  --------------  ------  --------------  ------  --------------  ----------- 
 

Resolution 3 - Approval of the Remuneration Policy

The Company was pleased that the new remuneration policy was supported in a vote at today's Annual General Meeting. It also notes that a significant minority were not able to support the new policy at this time. The Company undertook an in-depth consultation process with the majority of its largest shareholders in developing the revised policy and will continue to engage to ensure it fully understands the views of all shareholders on these matters, and to continue to explain the rationale for the changes.

Notes:

(1) The "for" votes include those giving the Chair discretion. In line with the notification issued to American Depositary Receipt (ADR) holders last year, GSK did not instruct its ADR Depositary to vote any unvoted ADRs in respect of the AGM resolutions.

   (2)      Votes "for" and "against" are expressed as a percentage of the total votes cast. 

(3) A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" or "against" a resolution.

   (4)      Indicates Special Resolutions requiring a 75% majority. 

The following table provides further information on participation in the AGM:

 
 
                                                          GSK's                 GSK's 
                                                  Twenty second          Twenty first 
                                                            AGM                   AGM 
                                               (Hybrid meeting)     (Virtual meeting) 
                                                         (2022)                (2021) 
 Issued share capital (excluding Treasury 
  Shares)                                         5,083,974,547         5,031,444,276 
                                            -------------------  -------------------- 
 Total votes cast and votes withheld 
  lodged as a % of GSK's issued share 
  capital (excluding Treasury Shares)                    70.25%                70.11% 
                                            -------------------  -------------------- 
 Total shareholder population                            89,764               100,906 
                                            -------------------  -------------------- 
 Total number of proxies lodged                           5,343                 6,089 
                                            -------------------  -------------------- 
 Number of shareholders in attendance              93 in person      142 participated 
                                                68 participated             virtually 
                                                      virtually 
                                            -------------------  -------------------- 
 % of shareholders who lodged proxies                     5.95%                 6.03% 
                                            -------------------  -------------------- 
 

The above poll results will shortly be available on the company's website at www.gsk.com . In accordance with Listing Rule 9.6.2, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the UK Listing Authority and will in due course be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

V A Whyte

Company Secretary

4 May 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGBKQBQABKDAPK

(END) Dow Jones Newswires

May 04, 2022 12:49 ET (16:49 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Gsk Charts.